LYFAX
Price
$12.01
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
37.24M
THISX
Price
$76.23
Change
+$0.11 (+0.14%)
Updated
Jun 5 closing price
Net Assets
11.27B
Interact to see
Advertisement

LYFAX vs THISX

Header iconLYFAX vs THISX Comparison
Open Charts LYFAX vs THISXBanner chart's image
AlphaCentric Life Sciences & Hlthcare A
Price$12.01
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets37.24M
T. Rowe Price Health Sciences I
Price$76.23
Change+$0.11 (+0.14%)
VolumeN/A
Net Assets11.27B
LYFAX vs THISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LYFAX vs. THISX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYFAX is a StrongSell and THISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
THISX has more cash in the bank: 11.3B vs. LYFAX (37.2M). LYFAX pays higher dividends than THISX: LYFAX (2.09) vs THISX (0.19). LYFAX was incepted earlier than THISX: LYFAX (6 years) vs THISX (9 years). LYFAX (1.91) is less costly to investors than THISX (0.67). LYFAX is a more actively managed with annual turnover of: 134.00 vs. THISX (52.40). LYFAX has a lower initial minimum investment than THISX: LYFAX (2500) vs THISX (500000). LYFAX annual gain was more profitable for investors over the last year : -0.55 vs. THISX (-19.25). LYFAX return over 5 years is better than : 10.17 vs. THISX (-10.74).
LYFAXTHISXLYFAX / THISX
Total Expense Ratio1.660.67248%
Annual Report Gross Expense Ratio1.910.67285%
Fund Existence6 years9 years-
Gain YTD-4.150-4.50492%
Front Load6%N/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets37.2M11.3B0%
Annual Yield % from dividends2.090.191,105%
Returns for 1 year-0.55-19.253%
Returns for 3 years10.29-10.86-95%
Returns for 5 years10.17-10.74-95%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLANX31.37N/A
N/A
DWS Latin America Equity A
GFVRX15.26N/A
N/A
Goldman Sachs Focused Value R
BCSIX46.00N/A
N/A
Brown Capital Mgmt Small Co Inv
CRBYX13.12N/A
N/A
Columbia Acorn Inst3
LGRCX21.70-0.23
-1.05%
Loomis Sayles Growth C